Burns Clinical Trial
Official title:
Effectiveness of Inhalation Aromatherapy In Children With Burns: A Randomized Controlled Trial
The study was carried out in the Pediatric Burn Unit, aged between 2 months and 7 years, with
no chronic pain, second degree superficial scald burns, hydrotherapy application, no burn
surgery, no pathogen growth in the burn site, the burn had not undergone epithelialization.
Children receiving routine analgesic therapy were included.
Lavender oil 15 minutes, Lavender oil 60 minutes and Jojoba oil 15 minutes (Placebo group)
were studied with a total of 108 children in three groups.
The children included in the study were randomized. One of the researchers measured the pain
and vital signs of children before the application. 0.5 cc of aromatherapy oil, which was
dripped into the gauze 15 or 60 minutes before the start of hydrotherapy and dressing, was
placed 20 cm away from the child's nose. The child who inhaled the smell was hydrotherapy and
dressing and then taken to bed. The other investigator, who did not know how long the child
inhaled in the morning, evaluated pain and vital signs 1 and 30 minutes after the child
returned to bed.
This randomized clinical trial research experimental design was performed with pediatric burn
patients on May 2018-May 2019. Routine treatment of any child was not interfered with during
the data collection phase of the study.
Sample
The minimum sample size in each intervention and control group was considered 36 using G
power formula with a = 0.05, power of 80%, 95% confidence interval (Gpower 3.1.9.2.,
Germany). Allocation to the groups was performed using the Stratified Randomization. The
absence of differences in age, vital signs and pain levels between groups prior to the
intervention was achieved using Stratified Randomization method.
Intervention Protocols
In the clinic where the study was conducted, all children are routinely given hydrotherapy
treatment for the examination of the burn area as of 10 am every morning and then dressings
are applied.
Besides routine care, the Control Group was treated with jojoba oil (Simmondsia Chinensis-
produced by Arifoğlu, obtained from jojoba fruits by cold squeezing method) inhalation
aromatherapy 15 minutes before Hydrotherapy. Jojoba oil was used as a placebo because it had
no specific odour. Besides routine care, Intervention-15 Group received lavender oil
(Lavandula angustifolia Miller Oleum-produced by Arifoğlu, obtained from lavender flowers by
water vapour distillation method) inhalation aromatherapy 15 minutes before Hydrotherapy and
besides routine care, Intervention-60 Group received lavender oil inhalation aromatherapy 60
minutes before Hydrotherapy. 0.5 ml (8.44 minim-imperial) of aromatherapy oil, which had been
dripped into 7.5x7.5 cm gauze 15 or 60 minutes before the start of Hydrotherapy, was placed
20 cm (7.87 inches) away from the child's nose by the clinical nurse. To conceal the
allocation, the group in which the child belongs is only known to the clinical nurse who has
placed the aromatherapy oil-soaked gauze in the child's room and this clinical nurse did not
carry out any assessment of the child's outcomes.
Data Collection
Before randomization, the characteristics of all participants were collected using the
Turkish version of the FLACC Pain Scale, Demographic Data Collection Form, and the Vital
Signs Follow-up Form which were developed by the researchers.
By the clinical nurse 0.5 ccs of aromatherapy oil, which had dripped into the gauze, was
placed 20 cm away from the child's nose. The child who inhaled the oil was then taken to
hydrotherapy and then dressing. The pain and vital signs of the child were evaluated and
recorded 1 minute and 30 minutes after the child returned to bed by a researcher who was
blind to the study groups.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05023135 -
DeepView SnapShot Portable (DV-SSP): Device Training Study
|
||
Completed |
NCT05276869 -
Reliability and Feasibility of WeeFIM Instrument to Measure Functional Independence in Pediatric Burns
|
||
Completed |
NCT04548635 -
VR for Burn Dressing Changes at Home
|
Phase 2/Phase 3 | |
Not yet recruiting |
NCT06076031 -
Effects of Applying Streaming Media on Reducing Pain in Patient With Second-degree Burn During Changing Dressing
|
N/A | |
Recruiting |
NCT05084248 -
Vitamin D Deficiency in Adults Following a Major Burn Injury
|
Phase 4 | |
Completed |
NCT03113253 -
TRANexamic Acid to Reduce Bleeding in BURN Surgery
|
Phase 4 | |
Recruiting |
NCT04090424 -
Assessment of Safety and Effectiveness of NovoSorb® BTM in Severe Burns
|
N/A | |
Not yet recruiting |
NCT05649891 -
Checklists Resuscitation Emergency Department
|
N/A | |
Withdrawn |
NCT03159182 -
Study of Silicone Material Inserts To Treat Burn Scars
|
N/A | |
Recruiting |
NCT02904941 -
Human Amniotic Versus Synthetic Membrane as a Transient Skin Cover for Pediatric Burns
|
N/A | |
Completed |
NCT02681757 -
Comparison of Mepitel Ag vs Antibiotic Ointment Used With Soft Cast Technique for Treatment of Pediatric Burns
|
N/A | |
Recruiting |
NCT01812941 -
Evaluation of Mitochondrial Dysfunction in Severe Burn and Trauma Patients
|
N/A | |
Completed |
NCT01437852 -
StrataGraft® Skin Tissue as an Alternative to Autografting Deep Partial-Thickness Burns
|
Phase 1 | |
Completed |
NCT01214811 -
Open Multi-centre Investigation to Evaluate Signs and Symptoms of Local Inflammation/Infection on Chronic Ulcers and Partial Thickness Burns When Using Mepilex Border Ag as an Anti-microbial Wound Dressing
|
Phase 3 | |
Completed |
NCT01061502 -
Efficacy Study of a Bioelectric Dressing to Treat Skin Graft Donor Site Wounds
|
Phase 1/Phase 2 | |
Terminated |
NCT00822796 -
Thermogard™ Efficacy Trial
|
N/A | |
Terminated |
NCT00634166 -
Effects of Therapy With Sulfamylon® 5% Topical Solution Compared to a Historical Control Group
|
Phase 4 | |
Terminated |
NCT00824681 -
Effect of Music Therapy on Families of Burn Patients
|
Phase 1 | |
Terminated |
NCT00464386 -
Continuous Glucose Monitoring (POC) in the ICU
|
N/A | |
Withdrawn |
NCT00216983 -
Proline Metabolism in Severely Burned Patients: Effect of Modulated Parenteral Feeding
|
N/A |